Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3316507 | 0.88 | — | — | |
| SCHEMBL5553124 | 0.83 | — | — | |
| SCHEMBL293941 | 0.80 | — | — | |
| SCHEMBL2956063 | 0.78 | — | — | |
| SCHEMBL5977475 | 0.75 | — | — | |
| SCHEMBL1743530 | 0.75 | — | — | |
| SCHEMBL4438002 | 0.75 | — | — | |
| SCHEMBL19846103 | 0.73 | TSHR (0.39) | TSHRMAPK1 | |
| SCHEMBL2776861 | 0.69 | — | — | |
| SCHEMBL11409749 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 65 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615656-B2 | Cycloaliphatic polyepoxy compounds and preparation thereof | DAICEL CHEMICAL INDUSTRIES, LTD. (JP) | 2009-11-10 | — | — | US | claimed |
| EP-2011811-B1 | ACTIVE RAY CURABLE COMPOSITION, ACTIVE RAY CURABLE INKJET INK, IMAGE FORMING METHOD USING THE ACTIVE RAY CURABLE INKJET INK, AND INKJET RECORDING APPARATUS | KONICA MINOLTA MED & GRAPHIC (JP) | 2015-03-18 | — | — | EP | disclosed |
| US-8642675-B2 | Actinic ray curable composition, actinic ray curable ink-jet ink, image forming method and ink-jet recording apparatus utilizing said actinic ray curable ink-jet ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2014-02-04 | — | — | US | disclosed |
| EP-2149457-B1 | Inkjet recording method, inkjet recording system, and printed material | FUJIFILM CORP (JP) | 2013-04-10 | — | — | EP | disclosed |
| EP-2347904-B1 | Ink set and ink-jet recording method utilizing uv-curable ink | KONICA MINOLTA MED & GRAPHIC (JP) | 2013-04-03 | — | — | EP | disclosed |
| EP-1829939-B1 | ACTIVE RAY-CURABLE INKJET INK AND IMAGE-FORMING METHOD USING SAME | KONICA MINOLTA MED & GRAPHIC (JP) | 2012-10-17 | — | — | EP | disclosed |
| EP-2347904-A2 | Inkset, ink-jet recording method and ink-jet recording device utilizing uv-curable ink | Konica Minolta Medical & Graphic, Inc. (JP) | 2011-07-27 | — | — | EP | disclosed |
| US-7950795-B2 | Image forming method and ink-jet recording device utilizing photo-curable ink, and inkset, ink-jet recording method and ink-jet recording device utilizing photo-curable ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2011-05-31 | — | — | US | disclosed |
| US-7749573-B2 | Actinic radiation curable ink-jet ink and image forming method using the same | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2010-07-06 | — | — | US | disclosed |
| US-20100144917-A1 | ACTINIC ENERGY RADIATION HARDENABLE COMPOSITION AND EPOXY COMPOUND | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2010-06-10 | — | — | US | disclosed |
| US-20050148687-A1 | Cationic polymerizable composition, actinic ray curable ink-jet ink and stabilization method of the cationic polymerizable composition | KONICA MINOLTA MEDICAL & GRAPHIC, INC | 2005-07-07 | — | — | US | disclosed |
| US-20050119362-A1 | Actinic ray curable composition, actinic ray crable ink, image formation method employing it, and ink-jet recording apparatus | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2005-06-02 | — | — | US | disclosed |
| US-20050020717-A1 | Actinic ray curable ink-jet ink and printed matter | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2005-01-27 | — | — | US | disclosed |
| EP-1500688-A1 | Actinic ray curable ink-jet ink and printed matter | Konica Minolta Medical & Graphic, Inc. (JP) | 2005-01-26 | — | — | EP | disclosed |
| US-20040252171-A1 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | KONICA MINOLTA MEDICAL & GRAPHIC, INC. | 2004-12-16 | — | — | US | disclosed |
| EP-1486526-A1 | Oxetane compound, actinic ray curable composition, ink composition for ink jet recording, and image formation method | Konica Minolta Medical & Graphic, Inc. (JP) | 2004-12-15 | — | — | EP | disclosed |
| US-20040244641-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2004-12-09 | — | — | US | disclosed |
| EP-1484370-A1 | Photocurable ink, and image recording apparatus and image recording method employing the photocurable ink | Konica Minolta Medical & Graphic, Inc. (JP) | 2004-12-08 | — | — | EP | disclosed |
| US-20040241578-A1 | Photocurable ink, and image recording apparatus and image recording method employing the photocurable ink | KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) | 2004-12-02 | — | — | US | disclosed |
| US-20040167315-A1 | Active energy ray curable composition | KONICA MINOLTA HOLDINGS, INC. (JP) | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040244641-A1 | Active ray curable ink-jet composition, image forming method using the same, ink-jet recording apparatus, and triarylsulfonium salt compound | JAK1, INO80, ROR1 | TSHR 3739/4885MAPK1 368/4885 |
| US-20100144917-A1 | ACTINIC ENERGY RADIATION HARDENABLE COMPOSITION AND EPOXY COMPOUND | EEF1A1, RAD51, EPN1 | TSHR 4380/4885MAPK1 788/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.